
Opinion|Videos|December 20, 2024
Important Background Information on RSV for Pharmacists
Traci M. Poole, PharmD, BCACP, BCGP, discusses the pathophysiology of respiratory syncytial virus (RSV) and its key complications, identifies high-risk populations for severe RSV infection, and explores best practices for recognizing these patients and ensuring they receive timely vaccination to prevent serious outcomes.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- What is the pathophysiology of RSV, and what key complications may occur?
- What are the high-risk populations for getting severe RSV infection?
- What are the best practices for identifying these patients and ensuring they are vaccinated against RSV?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Baxdrostat as First-in-Class Aldosterone Synthase Inhibitor for Hypertension
2
FAQ: Guidance for Pharmacists, SSRIs Under Scrutiny and Political Debate
3
Insulin Deprescribing Utilizing Continuous Glucose Monitoring With Low-Dose Tirzepatide
4
FDA Approves Immgolis and Immgolis Intri as First Biosimilars to Golimumab Reference Products for RA and UC
5


































































































































